MD Anderson - Orlando

Phase	Trial	Trial Status	Site Status	Drug	NCT#
3	A Phase 3 Study to Evaluate Efficacy and Safety of Masitinib in Comparison to Imatinib in Patients With Gastro-Intestinal Stromal Tumour in First Line Medical Treatment	Unknown	Active	Masitinib, (AB1010)	NCT00812240